These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9595134)

  • 1. Immunosuppressive approaches to the prevention of graft vascular disease.
    Gregory CR
    Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppressive agents: recent developments in molecular action and clinical application.
    Gerber DA; Bonham CA; Thomson AW
    Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y; Waer M
    Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
    [No Abstract]   [Full Text] [Related]  

  • 4. New immunosuppressive agents for organ transplantation.
    Waer M
    Acta Clin Belg; 1997; 52(4):199-203. PubMed ID: 9351290
    [No Abstract]   [Full Text] [Related]  

  • 5. Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies.
    Hausen B; Morris RE
    Clin Chest Med; 1997 Jun; 18(2):353-66. PubMed ID: 9187827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
    Morris RE; Huang X; Gregory CR; Billingham ME; Rowan R; Shorthouse R; Berry GJ
    Transplant Proc; 1995 Jun; 27(3):2068-9. PubMed ID: 7792888
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in immunosuppression for heart transplantation.
    Kobashigawa JA
    Adv Card Surg; 1998; 10():155-74. PubMed ID: 9917904
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 10. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis.
    Zucker MJ; Baran DA; Arroyo LH; Goldstein DJ; Neacy C; Mele L; Weinberg AD; Prendergast TW; Ribner HS
    Transplant Proc; 2005 Jun; 37(5):2231-9. PubMed ID: 15964386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved immunosuppression with combination tacrolimus (FK506) and mycophenolic acid in orthotopic liver transplantation.
    Cai TH; Esterl RM; Nichols L; Cigarroa F; Speeg KV; Halff GA
    Transplant Proc; 1998 Jun; 30(4):1413-4. PubMed ID: 9636572
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintenance pharmacological immunosuppressive strategies in renal transplantation.
    Vella JP; Sayegh MH
    Postgrad Med J; 1997 Jul; 73(861):386-90. PubMed ID: 9338020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and experimental immunosuppression.
    Castillo Lugo JA
    Bol Asoc Med P R; 1995; 87(5-6):106-8. PubMed ID: 8573248
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity.
    Flechner SM; Kobashigawa J; Klintmalm G
    Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New horizons in immunosuppression.
    Simmons RL; Wang SC
    Transplant Proc; 1991 Aug; 23(4):2152-6. PubMed ID: 1714645
    [No Abstract]   [Full Text] [Related]  

  • 16. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toward an evidence-based immunosuppression].
    Pascual J
    Nefrologia; 2001; 21(6):524-5; discussion 526-7. PubMed ID: 11881421
    [No Abstract]   [Full Text] [Related]  

  • 18. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
    Miki T; Goller A; Rao A; Wang X; Yin WY; Tandin A; Fung JJ; Starzl TE; Valdivia LA
    Transplant Proc; 1998 Jun; 30(4):1091-2. PubMed ID: 9636444
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapamycin for cardiac transplant rejection and vasculopathy: one stone, two birds?
    Edelman ER; Danenberg HD
    Circulation; 2003 Jul; 108(1):6-8. PubMed ID: 12847052
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation.
    Candinas D; Achilleos O; Lee SJ; Dalgic A; Mayer AD; Buckels JA; McMaster P; D'Silva M
    Transplant Proc; 1994 Dec; 26(6):3251-2. PubMed ID: 7527959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.